These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 3034401)

  • 21. A study of the effects of phorbol 12-myristate-13-acetate on cell differentiation of pure human melanocytes in vitro.
    Chao-Hsing KA; Hsin-Su YU
    Arch Dermatol Res; 1991; 283(2):119-24. PubMed ID: 1906266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factors in melanoma.
    Rodeck U; Herlyn M
    Cancer Metastasis Rev; 1991 Jun; 10(2):89-101. PubMed ID: 1873858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.
    Hunt KK; Shibata M; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1992; 34(6):377-82. PubMed ID: 1563014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M; Guerry D; Koprowski H
    J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
    Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
    Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
    Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture.
    Herlyn M; Rodeck U; Mancianti M; Cardillo FM; Lang A; Ross AH; Jambrosic J; Koprowski H
    Cancer Res; 1987 Jun; 47(12):3057-61. PubMed ID: 3034401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biology of tumor progression in human melanocytes.
    Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
    Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermis-derived stem cells: a source of epidermal melanocytes and melanoma?
    Zabierowski SE; Fukunaga-Kalabis M; Li L; Herlyn M
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):422-9. PubMed ID: 21410654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of cultured human melanocytes from different stages of tumor progression.
    Rodeck U; Herlyn M
    Cancer Treat Res; 1988; 43():3-16. PubMed ID: 2908575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The control of gene expression in melanocytes and melanomas.
    Eisen TG
    Melanoma Res; 1996 Aug; 6(4):277-84. PubMed ID: 8873046
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.